SARS-CoV-2, the virus that causes COVID-19 is constantly mutating itself, leading to the emergence of new variants. On 24 November 2021, the B.1.1.529 variant (Omicron) was first reported to WHO (World Health Organization) from South Africa, which has many mutations, some of which are concerning and further increase the risks.
The world has united against fighting the unprecedented pandemic and taking all the possible preventive measures such as aggressive testing, physical distancing, masks, vaccines, etc. to minimize the spread.
While mass-scale vaccination campaigns are ongoing worldwide, enhanced surveillance and sequencing efforts are need of the hour to monitor the emergence and global spread of viral variants of concern (VOC).
Read the latest publication on cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance to understand how I.DOT could be your choice in reducing the volume of each reagent and cutting the cost per sample for NGS (Next generation sequencing) Library preparation. DOI: 10.1038/s41467-021-24078-9